+0.0
net board stance
what this means
148.63
-1.1% · close 2026-09-08
+16% / +25% / +83%
1m / 3m / 12m
+23%
vs SPY since 2022-04-01
90%
of 52w range · -5.0% off high
—
hit rate as primary
Where we stand — 0 live ideas
No active idea holds this ticker. Anything below is history.
Where the winds are blowing
NET BOARD STANCE, LAST 60 EPISODES —
rising = the besties are building this position, falling = abandoning it. Replayed from
score_events; an idea counts from birth until its window closes.
PRICE VS SPY OVER THE SAME WINDOW, % — did the
talk lead the tape or follow it?
Who's pushing which way
each voice's net push ON THIS TICKER — their most recent stance per idea × the idea's direction × strength, so supporting a bearish idea pushes down. Not conviction (that lives on the idea); this is direction of travel per person. what w= means
Track record on MRK
No closed window has used this ticker as its primary play, so there is no scored record here yet. Adjacent plays are listed but never scored.
| idea | call | play | verdict | R | α | closed |
|---|---|---|---|---|---|---|
| 📈 Boosters + oral antivirals become the standard COVID stack | ▲ LONG | adjacent | HIT | +21.8% | +26.6 | 2022-07-30 |
| 🏛️ MFN drug-pricing EO compresses pharma profits and pushes R&D offshore | ▼ SHORT | adjacent | MISS | -40.2% | -65.9 | 2026-05-17 |
The tape — what was actually said
every capture on any idea holding MRK, newest first · quotes verbatim, timestamps deep-link into the episode
BE
Ben Shapiro
support ×2
▼ on
🏛️ MFN drug-pricing EO compresses pharma profits and pushes R&D offshore
E228 · 2025-05-17
▶ 1:30:48
So if you are talking about just artificially lowering prices by basically clocking Pharma, the reality is if you want to kill R&D, this is a great way to kill R&D.
You'll make 10 million bucks, which is not enough to fight this R&D battle. So if you then further affect the profitability scale of pharma, the impact is probably that we push R&D to different places.
I would be very cautious about the side effects that are going to arise from these protease inhibitors. ... I think as more people use them, you'll see more crazy stories about side effects that are really significantly adverse.
These new pills have, I think, a very good shot of doing it next year because they're protease inhibitors. ... I am hopeful that this will be the thing, hopefully, that ends the pandemic next year, are these new antiviral pills.
The only thing that seems to work is vaccines and booster shots. There's some good data around the third data, the third booster preventing serious cases.
I think that the combination of vaccines and what is equivalently Tamiflu for COVID, which is effectively what this is, is the one-two punch we need so that this basically is rendered.
We don't yet know if it reduces the transmission rate. So there's a lot of question marks on like, does this actually solve the problem of the pandemic? It's certainly another instrument to blunt the, you know, the impact.
Give me the third shot of Pfizer. And then I opened up Drudge Report yesterday. And it's like third shot of vaccine, a Pfizer in Israel or whatever. They're just going to start giving people a third shot. Yeah, I just want to get ahead of the curve.
there's one other piece of news that came out that I think is very positive on COVID, which is the availability of these oral antivirals, the pills. ... So I think that, you know, with the reduced effectiveness of vaccine, what we're going to have to do is supplement the vaccines and the boosters with home testing.